117 related articles for article (PubMed ID: 30067981)
1. Adaptive Fibrogenic Reprogramming of Osteosarcoma Stem Cells Promotes Metastatic Growth.
Zhang W; Zhao JM; Lin J; Hu CZ; Zhang WB; Yang WL; Zhang J; Zhang JW; Zhu J
Cell Rep; 2018 Jul; 24(5):1266-1277.e5. PubMed ID: 30067981
[TBL] [Abstract][Full Text] [Related]
2. Single-walled carbon nanotube: One specific inhibitor of cancer stem cells in osteosarcoma upon downregulation of the TGFβ1 signaling.
Miao Y; Zhang H; Pan Y; Ren J; Ye M; Xia F; Huang R; Lin Z; Jiang S; Zhang Y; Songyang Z; Zhang Y
Biomaterials; 2017 Dec; 149():29-40. PubMed ID: 28988062
[TBL] [Abstract][Full Text] [Related]
3. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
[TBL] [Abstract][Full Text] [Related]
5. Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.
Sabile AA; Arlt MJ; Muff R; Bode B; Langsam B; Bertz J; Jentzsch T; Puskas GJ; Born W; Fuchs B
J Bone Miner Res; 2012 Jan; 27(1):58-67. PubMed ID: 21976359
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect and significance of rapamycin on the mammalian target of rapamycin signaling pathway in osteosarcoma stem cells and osteosarcoma cells].
Liu PY; Zhang WB; Wang J; Shen YH; Wei YY
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):175-80. PubMed ID: 23879996
[TBL] [Abstract][Full Text] [Related]
7. Aberrant activation of wound healing programs within the metastatic niche facilitates lung colonization by osteosarcoma cells.
Reinecke JB; Gross AC; Cam M; Garcia LJ; Cannon MV; Dries R; Gryder BE; Roberts RD
bioRxiv; 2024 Jan; ():. PubMed ID: 38260361
[TBL] [Abstract][Full Text] [Related]
8. Intestinal organoids: a model of intestinal fibrosis for evaluating anti-fibrotic drugs.
Rodansky ES; Johnson LA; Huang S; Spence JR; Higgins PD
Exp Mol Pathol; 2015 Jun; 98(3):346-51. PubMed ID: 25828392
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells in osteosarcoma.
Brown HK; Tellez-Gabriel M; Heymann D
Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor β1 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma.
Zhang H; Wu H; Zheng J; Yu P; Xu L; Jiang P; Gao J; Wang H; Zhang Y
Stem Cells; 2013 Mar; 31(3):433-46. PubMed ID: 23225703
[TBL] [Abstract][Full Text] [Related]
11. Osteosarcoma-Derived Extracellular Vesicles Induce Lung Fibroblast Reprogramming.
Mazumdar A; Urdinez J; Boro A; Migliavacca J; Arlt MJE; Muff R; Fuchs B; Snedeker JG; Gvozdenovic A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751693
[TBL] [Abstract][Full Text] [Related]
12. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
13. Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.
Wang G; Sun M; Jiang Y; Zhang T; Sun W; Wang H; Yin F; Wang Z; Sang W; Xu J; Mao M; Zuo D; Zhou Z; Wang C; Fu Z; Wang Z; Duan Z; Hua Y; Cai Z
Int J Cancer; 2019 Aug; 145(4):979-993. PubMed ID: 30719715
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: FasL(+) immune cells promote resolution of fibrosis.
Wallach-Dayan SB; Elkayam L; Golan-Gerstl R; Konikov J; Zisman P; Dayan MR; Arish N; Breuer R
J Autoimmun; 2015 May; 59():67-76. PubMed ID: 25812467
[TBL] [Abstract][Full Text] [Related]
15. Gallium(iii)-polypyridyl complexes as anti-osteosarcoma stem cell agents.
Robin P; Singh K; Suntharalingam K
Chem Commun (Camb); 2020 Feb; 56(10):1509-1512. PubMed ID: 31917383
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer-derived extracellular vesicles stimulate myofibroblast differentiation and pro-angiogenic behavior of adipose stem cells.
Song YH; Warncke C; Choi SJ; Choi S; Chiou AE; Ling L; Liu HY; Daniel S; Antonyak MA; Cerione RA; Fischbach C
Matrix Biol; 2017 Jul; 60-61():190-205. PubMed ID: 27913195
[TBL] [Abstract][Full Text] [Related]
17. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.
Lamora A; Talbot J; Bougras G; Amiaud J; Leduc M; Chesneau J; Taurelle J; Stresing V; Le Deley MC; Heymann MF; Heymann D; Redini F; Verrecchia F
Clin Cancer Res; 2014 Oct; 20(19):5097-112. PubMed ID: 25107916
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo.
Hingorani P; Zhang W; Gorlick R; Kolb EA
Clin Cancer Res; 2009 May; 15(10):3416-22. PubMed ID: 19447875
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition.
Peng L; Jiang D
PLoS One; 2018; 13(10):e0205918. PubMed ID: 30356255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
